Product References
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
International journal of cancer
Roider T,Wang X,Hüttl K,Müller-Tidow C,Klapper W,Rosenwald A,Stewart JP,de Castro DG,Dreger P,Hermine O,Kluin-Nelemans HC,Grabe N,Dreyling M,Pott C,Ott G,Hoster E,Dietrich S
MA5-25298 was used in Western Blot, Flow Cytometry to evaluate the SAMHD1 protein as potential biomarker for the response to high-dose cytarabine in mantle cell lymphoma patients.
Fri Jan 01 00:00:00 UTC 2021
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
International journal of cancer
Roider T,Wang X,Hüttl K,Müller-Tidow C,Klapper W,Rosenwald A,Stewart JP,de Castro DG,Dreger P,Hermine O,Kluin-Nelemans HC,Grabe N,Dreyling M,Pott C,Ott G,Hoster E,Dietrich S
MA5-25298 was used in Western Blot, Flow Cytometry to evaluate the SAMHD1 protein as potential biomarker for the response to high-dose cytarabine in mantle cell lymphoma patients.
Fri Jan 01 00:00:00 UTC 2021
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
International journal of cancer
Roider T,Wang X,Hüttl K,Müller-Tidow C,Klapper W,Rosenwald A,Stewart JP,de Castro DG,Dreger P,Hermine O,Kluin-Nelemans HC,Grabe N,Dreyling M,Pott C,Ott G,Hoster E,Dietrich S
MA5-25298 was used in Western Blot, Flow Cytometry to evaluate the SAMHD1 protein as potential biomarker for the response to high-dose cytarabine in mantle cell lymphoma patients.
Fri Jan 01 00:00:00 UTC 2021
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
International journal of cancer
Roider T,Wang X,Hüttl K,Müller-Tidow C,Klapper W,Rosenwald A,Stewart JP,de Castro DG,Dreger P,Hermine O,Kluin-Nelemans HC,Grabe N,Dreyling M,Pott C,Ott G,Hoster E,Dietrich S
MA5-25298 was used in Western Blot, Flow Cytometry to evaluate the SAMHD1 protein as potential biomarker for the response to high-dose cytarabine in mantle cell lymphoma patients.
Fri Jan 01 00:00:00 UTC 2021